Clinical trial
Prospective Study to Determine the Optimum Age for Routine DEXA Screening for Osteopenia/Osteoporosis in People With HIV Infection
NCT01669954 is registered in ClinicalTrials.gov with King's College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study to Determine the Optimum Age for Routine DEXA Screening for Osteopenia/Osteoporosis in People With HIV Infection
- Lead sponsor
- King's College London
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- June 30, 2012
- Enrollment
- 440 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fractures, hiv infection, osteoporosis